Clinical trials
Hospitalized Children clinical trials
Below are recruiting hospitalized children clinical trials, each written for real people, not researchers. We’re tracking 1,199 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT02308917Recruiting
Canadian children's inflammatory bowel disease study
This study follows children with inflammatory bowel disease (IBD) to learn more about the disease and improve care. It may help doctors understand how to treat Crohn's disease, ulcerative colitis, or IBD that doesn't fit either diagnosis.
Calgary, AlbertaAges 2–17 - NCT06389084Recruiting
Parents together: supporting healthy habits in children
This study helps parents learn ways to encourage healthy habits in their children. It is for families already in the TARGet Kids! study.
Toronto, OntarioAges 2–5 - NCT07878065RecruitingPhase 3
Art and movement to ease anxiety in children with leukemia
This study tests whether art and movement activities can help reduce anxiety in children aged 8-13 who are being treated for acute lymphoblastic leukemia (a type of blood cancer) and are in the third stage of their treatment plan. If your child feels anxious, this program may help them feel calmer and more supported during treatment.
Cairo, Cairo GovernorateAges 8–13 - NCT06810583RecruitingPhase 1
Dalbavancin to prevent infections in children with high-risk leukemia
This trial tests whether an antibiotic called dalbavancin, given to prevent bacterial infections during chemotherapy-induced low white blood cell counts, is safe and works in children and young adults with certain types of leukemia. It may help reduce the risk of serious infections during treatment.
Memphis, TennesseeAges Up to 25 years - NCT05664113RecruitingPhase 1
Fecal transplant for gut problems after stem cell transplant
This study tests whether transplanting healthy donor stool into the gut can help children and young adults with ongoing digestive issues after a stem cell transplant. It may improve symptoms like diarrhea or the need for feeding tubes.
Memphis, TennesseeAges Up to 22 years - NCT07742358Recruiting
Comparing ureteral stent designs in children with kidney stones
This trial compares two types of ureteral stents (small tubes that help urine drain from the kidney to the bladder) in children having surgery for kidney stones. The goal is to see which type causes fewer symptoms like pain or discomfort.
Toronto, OntarioAges 8–18 - NCT05947045Recruiting
Virtual reality cognitive training during brain tumor radiotherapy
This trial tests whether a computer-based cognitive training program in a virtual reality setting can help children think and learn while they are getting radiation for a brain tumor. You and a parent will decide together if it’s a good fit, and the child must be able to complete the study tasks.
Memphis, TennesseeAges 8–22 - NCT06367192Recruiting
School Readiness Program for Preschoolers with Sickle Cell
This study tests a program to help preschoolers with sickle cell disease get ready for school. It looks at whether a special learning program can help with skills like paying attention and getting along with others.
Memphis, TennesseeAges 3.5 years–6.5 years - NCT07226219RecruitingPhase 1
Medication to help attention in children with sickle cell disease
This study tests whether a common medication called methylphenidate (often used for ADHD) can help children with sickle cell disease who have attention or memory problems. If the child qualifies, the study may offer a new way to improve focus and daily functioning.
Memphis, TennesseeAges 8–17 - NCT06554288RecruitingPhase 1
Trihexyphenidyl for dystonia in cerebral palsy
This study tests how a medicine called trihexyphenidyl works in children with dystonic cerebral palsy, a condition that causes muscle spasms. Researchers want to learn if a child’s genes affect how the medicine works and how the body processes it.
Kansas City, MissouriAges 5–17 - NCT04923126RecruitingPhase 1/Phase 2
Mirdametinib for children with low-grade brain tumors
This Phase 1/2 study tests mirdametinib, a targeted medicine, in children and young adults with low-grade glioma (a slower-growing brain tumor). It aims to find the best dose and see how well the treatment works, especially for tumors with certain “MAPK pathway” changes.
Memphis, TennesseeAges 2–24 - NCT06528691RecruitingPhase 2
Entrectinib for young children with NTRK/ROS1 brain tumors
This trial tests a targeted drug (entrectinib) in very young children (under 3) with a newly diagnosed brain tumor that has a specific genetic change (NTRK or ROS1 fusion). The drug works by blocking signals that help the tumor grow, and is given as the first treatment, before any chemotherapy or radiation.
Memphis, TennesseeAges Up to 3 years - NCT05535166RecruitingPhase 2
Risk- and lab-guided treatment for young children with medulloblastoma
This Phase 2 trial tests how doctors choose treatment for infants and young children with newly diagnosed medulloblastoma, based on MRI/CSF staging and lab testing of the tumor. It may help by matching therapy intensity to the child’s specific risk level and tumor type.
Palo Alto, CaliforniaAges Up to 4.9 years - NCT06023641RecruitingPhase 2
Liposomal irinotecan for children with rhabdomyosarcoma
This trial tests a new way to treat rhabdomyosarcoma using a targeted drug (liposomal irinotecan) based on the tumor's genetic makeup and risk group. It aims to improve outcomes for children and young adults with intermediate or high-risk disease.
Palo Alto, CaliforniaAges Up to 22 years - NCT07878156RecruitingPhase 3
Numbing medicine for children having brain tumor surgery
This study tests whether adding a numbing medicine to the standard pain block can reduce pain after brain surgery in children. It may help children feel more comfortable and recover more smoothly.
CairoAges Up to 18 years - NCT05124964Recruiting
Quality of life study for newly diagnosed brain germ cell tumors
This study looks at how life quality changes in children and young adults after a new diagnosis of a brain germ cell tumor. It may help doctors understand which supports improve day-to-day well-being.
BeijingAges 3–30 - NCT01515904Recruiting
Test of a teen obesity program team approach
This study evaluates the SickKids Team Obesity Management Program (STOMP) for teens with obesity. It looks to see how well this structured program and team support can help compared with typical participation.
Toronto, OntarioAges 12–18 - NCT01605266Recruiting
Study of insights in children with nephrotic syndrome
This study looks at children’s experiences and understanding of nephrotic syndrome using questionnaires. It aims to learn what helps families and children, which could improve care over time.
Brampton, OntarioAges 6 months–18 years - NCT02193841RecruitingPhase 3
Treating simple bone cysts in children with new bone support
This study looks at how well a treatment works for children with a simple bone cyst in an arm or leg. The goal is to prevent problems like fractures while the cyst heals, using a stabilizing implant in the bone.
Birmingham, AlabamaAges 2–21 - NCT07857746Recruiting
Outcomes of stem cell transplant in children
This study looks at how children who received a stem cell transplant at one hospital are doing. It aims to learn about their recovery and long-term results, which can help improve care for future patients.
Ratchathewi, BangkokAges Up to 18 years - NCT04442516Recruiting
Testing kidney injury risk from cisplatin cancer treatment
This study looks at how cisplatin chemotherapy affects the kidneys. It may help doctors better predict and protect against kidney damage when patients start cisplatin.
London, OntarioAges 3 months+ - NCT06153147Recruiting
Kidney & blood pressure in childhood cancer survivors
This study looks at kidney health and blood pressure in childhood cancer survivors. If you finished high-risk cancer therapy about 3 years ago, researchers want to see how your kidneys and blood pressure are doing now.
Toronto, OntarioAges Up to 19 years - NCT04559425Recruiting
Registry study for immune-related serious slowed fetal heart rhythm
This study follows pregnancies where the baby has a serious immune-related heart rhythm problem (high-grade AV block). It collects information to better understand what happens during pregnancy and after delivery, especially when blood tests show anti-Ro/La antibodies.
Phoenix, ArizonaAges 16–50 - NCT07830134Recruiting
Brain training for childhood medulloblastoma survivors
This study tests a brain-training method that uses real-time feedback to help improve memory and thinking in young people who survived medulloblastoma. It may help with everyday tasks like remembering things and staying focused.
Memphis, TennesseeAges 10–25
Hear when a new Hospitalized Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalized children?
- Yes. Clin2 currently lists 1,199 recruiting hospitalized children studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalized children trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalized children trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.